Filing Details
- Accession Number:
- 0001127602-25-004543
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-13 11:49:05
- Reporting Period:
- 2025-02-11
- Filing Date:
- 2025-02-13
- Accepted Time:
- 2025-02-13 11:49:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920148 | Labcorp Holdings Inc. | LH | Services-Medical Laboratories (8071) | 992588107 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1376841 | H Adam Schechter | 531 South Spring Street Burlington NC 27215 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-02-11 | 6,121 | $244.62 | 86,445 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2025-02-11 | 2,963 | $0.00 | 89,408 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-11 | 1,226 | $245.14 | 88,182 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Options | Acquisiton | 2025-02-11 | 33,100 | $0.00 | 33,100 | $245.14 |
| Common Stock | Restricted Stock Unit | Acquisiton | 2025-02-11 | 10,970 | $0.00 | 10,970 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2025-02-11 | 2,963 | $0.00 | 2,963 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 33,100 | 2026-02-11 | 2035-02-10 | No | 4 | A | Direct |
| 26,102 | No | 4 | A | Direct | ||
| 23,139 | No | 4 | M | Direct |
Footnotes
- Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
- Stock withholding to satisfy tax withholding obligations.
- Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.
- The option vests in three equal annual installments beginning on the date reflected in this column.
- The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026.
- This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
- The Restricted Stock Units vested in three equal annual installments beginning on February 11, 2023 and are now fully vested.
Billionaire Hedge Funds
